Dr. Richard Mark Imbach

DDS | Dentist



  
  4809 Leeds Ave, Baltimore
  Maryland, 21227

  410-242-1112    410-418-9579 Maps & Directions
Dr. Richard Mark Imbach is a Baltimore, Maryland based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 4809 Leeds Ave, Baltimore. Patients can reach him at 410-242-1112.
Dr. Richard Mark Imbach is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Richard Mark Imbach speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Richard Mark Imbach
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:4809 Leeds Ave, Baltimore,
Maryland, 21227
Phone:410-242-1112
Fax:410-418-9579
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 7719283183
Enrollment ID: I20160310001287
NPI Number: 1790920759
NPI Enumeration Date: 04 Dec, 2008
NPI Last Update On: 04 Dec, 2008

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 4809 Leeds Ave,
Baltimore, Maryland
Zip: 21227
Phone Number: 410-242-1112
Fax Number: 410-418-9579
Patients can reach Dr. Richard Mark Imbach at 4809 Leeds Ave, Baltimore, Maryland or can call to book an appointment on 410-242-1112. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: